Symptoms
Symptoms
of Lung Cancer (Onconurse.com)
Describes the symptoms and syndromes associated with lung cancer.
Includes pulmonary symptoms, symptoms in other organs, symptoms linked
to tumor metabolism, blood (hematologic) symptoms, vein and artery (vascular)
syndromes, skin (cutaneous) syndromes, musculoskeletal syndromes, nervous
system (neurologic) syndromes, and hormonal (endocrine) syndromes. [2000]
Clinical
Manifestations (symptoms) of Lung Cancer (National Center
for Biotechnology Information)
by Holland & Frei et al.
Cancer Medicine, 6th ed. Hamilton, Canada: BC Decker, Inc,
2003
Interesting chart showing the frequency of clinical manifestations
(symptoms) of both SCLC and NSCLC. [2003]
Initial
Evaluation of the Patient with Lung Cancer: Symptoms, Signs, Laboratory
Tests, and Paraneoplastic Syndromes (CHEST)
Abstract of the evidence-based lung cancer treatment guideline published
by the American College of Chest Physicians (ACCP) in the supplement to
the January 2003 issue of CHEST. Outlines the components of the initial
evaluation for lung cancer, which are based on symptoms related to the
primary tumor, intrathoracic spread of lung cancer, and patterns of metastatic
dissemination. Points out the features of the history and physical signs
that may be useful indicators of the extent of disease. Discusses how
the standardized evaluation, relying on symptoms, signs, and routinely
available laboratory tests, can serve as a useful screen for metastatic
disease. Describes the common features of the various paraneoplastic syndromes
associated with lung cancer. Additional recommendations and assessments
are included. Aimed at physicians. [1/03]
Neoplastic & Paraneoplastic
Syndromes Associated with Lung Cancer (Lung Cancer Online)
Links to information on Pancoast Syndrome, Superior Vena Cava (SVC)
Syndrome, Clubbing & Hypertrophic Osteoarthropathy, Hypercalcemia,
Hyponatremia and Syndrome of Inappropriate Secretion of Antidiurectic
Hormone (SIADH).
How Is Lung Cancer
Diagnosed?
Diagnosis
of Lung Cancer: The Guidelines (CHEST)
Abstract of the evidence-based lung cancer treatment guideline published
by the American College of Chest Physicians (ACCP) in the supplement to
the January 2003 issue of CHEST. Lung cancer is usually suspected in individuals
who have abnormal chest radiograph findings or have symptoms caused by
either local or systemic effects of the tumor. The method of diagnosis
of suspected lung cancer depends on the type of lung cancer (ie, SCLC
or NSCLC), the size and location of the primary tumor, the presence of
metastasis, and the overall clinical status of the patient. This guideline
considers all manner of clinical presentations of lung cancer in light
of currently available diagnostic procedures and makes recommendations
to provide clinicians with guidance as to the most efficient approach
to the diagnosis of lung cancer in individual patients. Aimed at physicians.
[1/03]
Medical
History and Physical Exam for Lung Cancer (Hoag Hospital)
Provides an overview of what to expect during your medical examination.
Explains what information your doctor is looking for and why. [5/01]
Tests & Procedures
(Lung Cancer Online)
Links to information on imaging tests and biopsy methods used to
diagnose and stage lung cancer, including CT scan, bronchoscopy, mediastinoscopy,
and fine needle aspiration biopsy, among others.
Tumor Markers (Lung Cancer
Online)
Links to information on tumor markers used to aid in the diagnosis
and management of lung cancer.
Pathology
& Your Diagnosis (CURE)
by Melissa Weber
v.2, no.4 CURE (Winter 2003)
Discusses the role of the pathologist and explains how pathology
is used in the diagnosis of cancer. Describes pathological examination,
including immunohistochemistry and molecular testing. Stresses the importance
of an accurate diagnosis. [2/03]
Diagnostic Dilemmas
Histology
of Synchronous Pulmonary Nodules (ASCO Abstract)
Addresses the clinical dilemma presented by the simultaneous discovery
of two pulmonary nodules occurring in different lobes or lungs. These
lesions could be either benign or malignant; if both are malignant they
could represent a metastatic process or synchronous primary lung cancers.
Study results underscore the importance of addressing each lesion independently.
[2000]
|
